Stock Watch: Lilly’s Emgality Trod A Well-Beaten Path To Clinical Failure
Beware The Clinical Trial Comparator Arm
The outcome of any clinical study is uncertain but the choice of active comparator and sometimes even the placebo arm can magnify unpredictability. Emgality’s recent head-to-head failure in migraine is just the latest in a long list of casualties.
